Evidence map›Paper›PMID 21149584›Full record

ArticleInfection and immunity2011

The tetraspanin CD82 is specifically recruited to fungal and bacterial phagosomes prior to acidification.

Katerina Artavanis-Tsakonas, Pia V Kasperkovitz, Eliseo Papa, Michael L Cardenas, Nida S Khan, Annemarthe G Van der Veen, Hidde L Ploegh, Jatin M Vyas

Abstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CD82 controls CpG-dependent TLR9 signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. MacrophageCurrent fungal infection reports · 2014
    Article
  13. Pancreatic cancer diagnosis by free and exosomal miRNA.World journal of gastrointestinal pathophysiology · 2013
    Review
  14. Article
  15. The cell biology of the innate immune response to Aspergillus fumigatus.Annals of the New York Academy of Sciences · 2012
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Katerina Artavanis-TsakonasWhitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
Pia V Kasperkovitz
Eliseo Papa
Michael L Cardenas
Nida S Khan
Annemarthe G Van der Veen
Hidde L Ploegh
Jatin M Vyas
Massachusetts General Hospital · USWhitehead Institute for Biomedical Research · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
ASSEMBLY AND TRAFFICKING OF MHC CLASS II MOLECULESR01AI034893 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 1994 to 2008
$4.0M
Functional Role of the Tetraspanin CD82/Kai1 in Innate and Adaptive ImmunityR01AI092084 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2011 to 2015
$2.2M
Modulation of Dendritic Cell Function by CytomegalovirusK08AI057999 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2004 to 2008
$605k
Trafficking of CD82 and CD63 tetraspaninsF32CA105862 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI ARTAVANIS-TSAKONAS, KATERINA G · 2004 to 2006
$142k
NCI NIH HHS 1F32CA105862-01NCI NIH HHS F32 CA105862NIAID NIH HHS 5K08AI57999NIAID NIH HHS 5R01AI034893-17NIAID NIH HHS K08 AI057999NIAID NIH HHS R01 AI034893NIAID NIH HHS R01 AI092084NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

CD82 is a member of the tetraspanin superfamily, whose physiological role is best described in the context of cancer metastasis. However, CD82 also associates with components of the class II major histocompatibility complex (MHC) antigen presentation pathway, including class II MHC molecules and the peptide-loading machinery, as well as CD63, another tetraspanin, suggesting a role for CD82 in antigen presentation. Here, we observe the dynamic rearrangement of CD82 after pathogen uptake by imaging CD82-mRFP1 expressed in primary living dendritic cells. CD82 showed rapid and specific recruitment to Cryptococcus neoformans-containing phagosomes compared to polystyrene-containing phagosomes, similar to CD63. CD82 was also actively recruited to phagosomes containing other pathogenic fungi, including Candida albicans and Aspergillus fumigatus. Recruitment of CD82 to fungal phagosomes occurred independently of Toll-like receptor (TLR) signaling. Recruitment was not limited to fungi, as bacterial organisms, including Escherichia coli and Staphylococcus aureus, also induced CD82 recruitment to the phagosome. CD82 intersected the endocytic pathway used by lipopolysaccharide (LPS), implicating CD82 in trafficking of small, pathogen-associated molecules. Despite its partial overlap with lysosomal compartments, CD82 recruitment to C. neoformans-containing phagosomes occurred independently of phagosome acidification. Kinetic analysis of fluorescence imaging revealed that CD82 and class II MHC simultaneously appear in the phagosome, indicating that the two proteins may be associated. Together, these data show that the CD82 tetraspanin is specifically recruited to pathogen-containing phagosomes prior to fusion with lysosomes.

Indexed as

AnimalsAntigen-Presenting CellsCryptococcosisCryptococcus neoformansEscherichia coliEscherichia coli InfectionsFluorescent Antibody TechniqueHeLa CellsHumansImmunoprecipitationKangai-1 ProteinMiceMicroscopy, ConfocalPhagosomesProtein TransportStaphylococcal InfectionsCd82 antigen, mouseCD82 protein, humanKangai-1 Protein

Identifiers

PMID21149584
PMCPMC3067484
OpenAlexW2164813052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.